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doi:10.1Objective: Deep hypothermic circulatory arrest (DHCA) and antegrade cerebral perfusion (ACP) are 2 cardio-
pulmonary bypass strategies mainly used in aortic arch reconstructions. It has been suggested that during ACP,
abdominal organs are better protected than during DHCA owing to partial perfusion via collaterals. We tested
this hypothesis using intraoperative near-infrared spectroscopy (NIRS), lactate measurements, and biomarkers
for early abdominal injury in neonates undergoing complex aortic arch repair.
Methods: Neonates scheduled for aortic arch reconstruction via median sternotomy between 2009 and 2011
were randomized to either DHCA or ACP. During surgery, regional oxygen saturations of the abdomen were
monitored using NIRS. Immediately aafter DHCA or ACP, lactate concentrations from the inferior vena cava
were compared with those from the arterial cannula. Postoperatively, biomarkers for early abdominal organ in-
jury were measured in urine.
Results: Twenty-five neonates were analyzed (DHCA, n ¼ 12; ACP, n ¼ 13). Procedures were performed at
18C, and ACP flow was set at 35 to 50 mL $ kg1 $ min1. Median abdominal NIRS value during DHCA
was 31% (IQR, 28%-41%) whereas during ACP it was 56% (IQR, 34%-64%; P<.01 between groups). Im-
mediately after DHCA, median lactate from the inferior vena cava was 4.2 mmol/L (IQR, 3.3-5.3 mmol/L) com-
pared with 3.1 mmol/L (IQR, 2.9-4.4 mmol/L) after ACP (P ¼ .03). Postoperatively, biomarkers for renal and
intestinal damage (gluthatione s-transferase and intestinal fatty acid binding protein, respectively) were higher
in the DHCA group than for the ACP group (P ¼ .03, P ¼ .04, respectively).
Conclusions: These results substantiate earlier suggestions that ACP provides more abdominal organ protection
than DHCA in neonates undergoing aortic arch reconstruction. (J Thorac Cardiovasc Surg 2012;144:1323-8)Earn CME credits at
http://cme.ctsnetjournals.orgSupplemental material is available online.
Deep hypothermic circulatory arrest (DHCA) and ante-
grade cerebral perfusion (ACP) are 2 cardiopulmonary by-
pass (CPB) strategies applied in neonatal aortic arch repair.
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The Journal of Thoracic and Carinnominate artery. Most studies are focused on the neuro-
logic effects of either technique.1,2 However, abdominal
organ functions also deserve attention inasmuch as
postoperative renal function, for instance, is closely
related to general postoperative recovery.3 Recently, we4
have shown that duration of postoperative recovery in-
creases with longer duration of DHCA, whereas duration
of ACP has no effect. It is thought that this is due to partial
perfusion of the viscera through collaterals during ACP.5-8
Others have reported evidence of regional blood flow by
abdominal near-infrared spectroscopy (NIRS) or blood
pressure measurements in the abdominal or femoral ar-
teries.5,7,8 Still, to date, the protective effect of ACP has
remained a speculation, inasmuch as abdominal organ
injury has not been directly assessed perioperatively.
Various organ-specific biomarkers have proved useful to
estimate the extent of abdominal organ injury at an early
time point after cardiac surgery or other intensive care set-
tings.9 For renal injury, neutrophil gelatinase-associated lip-
ocalin (NGAL) is the most widely reported marker; others
include kidney injury molecule-1 (KIM-1), liver fatty acid
binding protein (L-FABP), gluthatione s-transferase
(GST) and N-acetyl-b-D-glucosaminidase (NAG).10-17
For intestinal injury, intestinal fatty acid binding protein
(I-FABP) is an established early biomarker.18,19diovascular Surgery c Volume 144, Number 6 1323
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
GST ¼ gluthatione s-transferase
I-FABP ¼ intestinal fatty acid binding protein
IQR ¼ interquartile range
KIM-1 ¼ kidney injury molecule-1
L-FABP ¼ liver fatty acid binding protein
NAG ¼ N-acetyl-b-D-glucosaminidase
NGAL ¼ neutrophil gelatinase-associated
lipocalin
NIRS ¼ near-infrared spectroscopy
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DIn this study, we assessed the above-named biomarkers of
early abdominal injury in neonates undergoing aortic arch
reconstructions, before and after surgery. Furthermore, ab-
dominal NIRS and lactate measurements were performed
intraoperatively to estimate abdominal perfusion. We hy-
pothesised that ACP would provide more abdominal perfu-
sion and consequently result in less renal and intestinal
injury than DHCA.METHODS
Patients and Surgical Procedures
The current study was performed as part of a prospective randomized
controlled trial comparing the neurologic effects of DHCA and ACP
(clinicaltrials.gov number NCT01032876). In the subgroup reported
here, data on abdominal perfusion were collected; these consisted of intra-
operative abdominal NIRS monitoring and lactate measurements and pre-
operative and postoperative urine analysis of biomarkers for early
abdominal injury. The institutional medical ethics committee approved
the study and all parents gave informed consent for enrollment. Patients
in whom a congenital syndrome was suspected were not eligible for inclu-
sion in the study.
In all patients, surgery was performed through a median sternotomy and
standard cannulation techniques with double venous cannulation were
applied. In case of interrupted aortic arch, double cannulation of the distal
ascending aorta and the pulmonary trunk was performed. CPB was per-
formed using alpha-stat strategy, and patients were cooled for a minimum
of 20 minutes to a nasopharyngeal temperature of 18C. ACP was per-
formed directly by advancing the arterial cannula into the innominate
artery. In the case of a Norwood procedure with a modified Blalock-
Taussig shunt, the shunt was anastomosed to the innominate artery before
aortic arch reconstruction and the shunt was used to deliver ACP. A target
flow rate of 25% (35-50 mL $ kg1 $ min1) was used with a perfusate
temperature of 18C and right radial pressures not exceeding 40 mm Hg.
Depending on the individual anatomic situation, the aortic arch was recon-
structed by direct end-to-end or end-to-side anastomosis, reverse subcla-
vian flap and patch plasty, or patch plasty alone. All procedures were
performed by a single surgical team.
NIRS Measurements
Throughout the perioperative period, regional saturations of the frontal
cerebrum and the abdomen were estimated using NIRS. For somatic mea-
surement, the electrode (size Pediatric, INVOS, Somanetics, Troy, Mich)1324 The Journal of Thoracic and Cardiovascular Surwas placed longitudinally on the left flank, just caudal of the costal margin.
The electrode positioning was verified using ultrasound in the first 10
patients, all showing placement over the left kidney. Mean values of the
following 4 periods were calculated: preoperative (minimum of 6 hours
of monitoring), deep hypothermic full-flow CPB, during DHCA or ACP,
and during the first 30 minutes after reinstitution of normal CPB.
Lactate Measurements
When aortic arch reconstruction was completed and full-body CPB re-
instituted, blood samples were simultaneously drawn from the arterial can-
nula and the snugged inferior venous cannula within the first minute of
reperfusion. After the inferior venous cannula had been temporarily
clamped and the first 10 mL of blood discarded (as this approximates the
dead space of the cannula), a sample of 0.5 mL of blood was drawn from
the inferior vena cava for determination of lactate concentration.
Urine Analysis for Biomarkers
Urine samples were collected preoperatively and postoperatively. Pre-
operatively, urine was collected before initiation of CPB, and the postoper-
ative time point consisted of urine produced during the second hour after
skin closure. NGAL, KIM-1, L-FABP, and I-FABP were measured using
enzyme-linked immunosorbent assay. GST (total of a and p) and NAG
were measured using colorimetric enzymatic assay. Biomarkers of organ
injury were assessed at HaemoScan, Groningen, The Netherlands. Markers
were additionally expressed as a ratio of urine production in milliliters per
kilogram per hour to correct for dilution of urine.20
Statistical Analysis
Data in text are stated as median (interquartile range [IQR]) or number
of patients (percentage of group) unless noted otherwise. Differences in
continuous variables between DHCA and ACP groups were compared us-
ing theMann-WhitneyU test. SignalBase version 6.76 (UniversityMedical
Center Utrecht, The Netherlands) was used for calculation of NIRS values.
SPSS version 15.0 (SPSS, Inc, Chicago, Ill) was used for statistical analy-
ses and GraphPad Prism version 5.03 (GraphPad Software, La Jolla, Calif)
was used for graphic figures.
RESULTS
Patients and Surgical Data
Specific diagnoses and surgical data are listed in Table 1.
Eight neonates underwent univentricular repair, whereas
the other 17 underwent biventricular repair. According to
the randomization protocol, 12 neonates underwent surgery
with DHCA and 13 neonates with ACP.
One patient from the DHCA group died within 30 days
postoperatively. Low cardiac output syndrome and renal
failure developed, which required peritoneal dialysis at 18
days postoperatively. The patient died 1 week later. None
of the other patients had any abdominal complications.
Systemic Saturation and Cerebral NIRS
The preoperative oxygenation status was similar in both
groups. Before the start of CPB, the median systemic satu-
ration in the DHCA group was 97% (IQR, 93%-100%) and
for the ACP group this was 98% (IQR, 95%-99%). Re-
garding preoperative cerebral NIRS values, the DHCA
group had a median of 59% (IQR, 54%-67%) vs a median
of 62% (IQR, 54%-67%) for ACP. At deep hypothermic
full flow, the DHCA group had a median cerebral NIRSgery c December 2012
TABLE 1. Patient characteristics and operative data
DHCA (n ¼ 12) ACP (n ¼ 13)
Age at operation (d) 9 (8-11) 9 (8-23)
Weight at operation (kg) 3.6 (3.2-3.8) 3.6 (2.5-3.7)
Gestational age at birth (wk) 39 (38.3-40.0) 39 (38.3-40.0)
Cardiac diagnoses, biventricular repair (n ¼ 17):
Hypoplastic aortic arch/CoA, plus:
No intracardiac defects 0 1
VSD 1 3
ASD 0 1
cAVSD 1 0
TGA 1 0
Aortic valve stenosis 0 1
Double-outlet right ventricle 1 1
Interrupted aortic arch, plus:
VSD, ASD 0 1
Severe LVOTO (Ross-Konno
procedure)
1 0
TGA 1 0
Hypoplastic left heart complex* 0 3
Univentricular repair (n ¼ 8):
Hypoplastic left heart syndrome 4 1
Double-inlet left ventricle 0 1
Tricuspid atresia 2 0
CPB data:
Cooling duration (min) 35 (30-40) 30 (29-38)
Duration of DHCA or
ACP (min)
33 (28-38) 39 (32-49)
Total CPB duration 167 (142-266) 161 (129-169)
ACP flow rate
(mL $ kg1 $ min1)
46 (41-49)
Nasopharyngeal temperature
during DHCA/ACP (C)
17.3 (16.5-18.0) 17.7 (17.4-18.3)
Rectal temperature during
DHCA/ACP (C)
20.7 (20.0-21.8) 20.7 (19.4-21.9)
Values shown in median (interquartile range) or number of patients.DHCA, Deep hy-
pothermic circulatory arrest; ACP, antegrade cerebral perfusion; CoA, coarctation of
the aortic arch; VSD, ventricular septal defect; ASD, atrial septal defect; cAVSD, com-
plete atrioventricular septal defect; TGA, transposition of the great arteries; LVOTO,
left ventricular outflow tract obstruction; CPB, cardiopulmonary bypass. *Hypoplas-
tic left heart complex was defined as an underdevelopment of the left heart with sig-
nificant hypoplasia of the left ventricle and hypoplasia of the aortic and/or mitral
valve, ascending aorta and aortic arch, but in the absence of intrinsic valvular stenosis
or atresia.21
FIGURE 1. Abdominal near-infrared spectroscopy (NIRS) values are
lower during deep hypothermic circulatory arrest (DHCA) than during an-
tegrade cerebral perfusion (ACP) (*P<.01). Values are shown in medians
and interquartile ranges (boxes) and minimum and maximum values (whis-
kers). ACP, Antegrade cerebral perfusion;DHCA, deep hypothermic circu-
latory arrest; NIRS, near-infrared spectroscopy.
FIGURE 2. Arterial lactate concentrations are similar between deep hy-
pothermic circulatory arrest (DHCA) and antegrade cerebral perfusion
(ACP), whereas lactate concentrations from the inferior vena cava (IVC)
are significantly higher after DHCA than after ACP (*P ¼ .03). Values
are shown in medians and interquartile ranges (boxes) and minimum and
maximum values (whiskers).
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Dof 80% (IQR, 70%-92%), which was 79% (IQR, 72%-
85%) in the ACP group. During DHCA a median of 51%
was observed (IQR, 49%-54%) vs 80% (IQR, 70%-
88%) during ACP. During reperfusion, saturations were
74% (IQR, 71%-79%) for the DHCA group and 73%
(IQR, 66%-78%) for the ACP group.
Abdominal NIRS
Abdominal NIRSmeasurements are depicted in Figure 1.
Before surgery, abdominal NIRS values were similar in the
2 groups, with a median of 53% (IQR, 49%-59%) in the
DHCA group and 56% (IQR, 48%-72%) in the ACP
group. At deep hypothermic full-flow CPB, the DHCAThe Journal of Thoracic and Cargroup had a median saturation of 89% (IQR, 79%-94%),
which was 77% (IQR, 68%-92%) in the ACP group. Dur-
ing DHCA, abdominal NIRS values decreased to a median
of 31% (IQR, 28%-41%), which was significantly lower
than during ACP (median, 56% [IQR, 36%-64%];
P<.01). During the first 30 minutes after reinstitution of
normal CPB, the DHCA group had a median value of
74% (IQR, 67%-87%) whereas this was 83% (IQR,
76%-91%) in the ACP group.Lactate Measurements
Lactate measurements were collected in all but 3 neo-
nates (DHCA, n ¼ 11; ACP, n ¼ 11) and are shown in
Figure 2. Lactate concentrations from the arterial cannula
and from the inferior vena cava were compared. Arterial
lactate values were similar between DHCA and ACPdiovascular Surgery c Volume 144, Number 6 1325
TABLE 2. Abdominal biomarker results
DHCA ACP P value postop
(DHCA vs ACP)Preop (n ¼ 9) Postop (n ¼ 11) Preop (n ¼ 10) Postop (n ¼ 12)
Absolute urinary concentrations
Renal injury
NGAL 89 (4.6-149) 185 (92-235) 27 (9.2-60) 47 (24-117) .07
GST 5.2 (2.4-6.0) 7.2 (5.3-7.9) 5.4 (2.0-6.7) 3.8 (2.2-6.1) .03
L-FABP 128 (55-426) 262 (43-421) 83 (34-312) 132 (22-607) .61
NAG 8.6 (0.9-18) 39 (9.7-67) 8.1 (2.7-20) 24 (6.2-53) .50
KIM-1 2.7 (0.7-6.3) 1.5 (0.6-10.0) 1.1 (0.4-2.3) 0.6 (0.2-2.8) .14
Intestinal injury
I-FABP 11 (6.7-90) 82 (30-180) 15 (7.9-38) 11 (0.0-101) .04
Results corrected for urine output
Renal injury
NGAL 19 (1.2-78) 119 (84-136) 11 (5.3-22) 14 (5.8-53) <.01
GST 1.2 (0.5-3.7) 4.7 (2.8-5.9) 0.9 (0.3-2.4) 1.4 (0.3-2.5) .02
L-FABP 83 (13-280) 271 (39-541) 37 (5.6-101) 19 (9.6-88) .03
NAG 3.8 (0.1-7.6) 26 (4.4-61) 2.3 (1.1-5.6) 5.1 (1.5-26) .11
KIM-1 0.5 (0.1-4.3) 1.4 (0.2-7.8) 0.4 (0.2-1.0) 0.4 (0.03-1.0) .05
Intestinal injury
I-FABP 6.6 (1.5-65) 19 (59-134) 3.9 (0.00-13) 1.5 (0.00-39) .01
Urine output (mL $ kg1 $ h1) 4.2 (2.4-6.8) 1.5 (0.8-3.1) 4.0 (2.4-5.8) 2.8 (1.4-6.3) .10
Values are shown in median (interquartile range). DHCA, Deep hypothermic circulatory arrest; ACP, antegrade cerebral perfusion; NGAL, neutrophil gelatinase-associated lip-
ocalin (ng/mL); GST, gluthatione s-transferase (U/mL); L-FABP, liver fatty acid binding protein (ng/mL); NAG, N-acetyl-b-D-glucosaminidase (mU/mL); KIM-1, kidney injury
molecule-1 (ng/mL); I-FABP, intestinal fatty acid binding protein (ng/mL).
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D(median DHCA, 2.8 mmol/L [IQR, 2.2-3.4 mmol/L]; me-
dian, ACP, 2.9 mmol/L [IQR, 2.4-3.9 mmol/L]). After
DHCA, lactate from the inferior vena cava had a median
of 4.2 mmol/L (IQR, 3.3-5.3 mmol/L), which was signifi-
cantly higher than the caval lactate in the ACP group (me-
dian, 3.1 mmol/L [IQR, 2.9-4.4 mmol/L]; P ¼ .03).
Abdominal Biomarkers
Biomarkers of renal and intestinal injury were measured
preoperatively in 19 neonates (DHCA, n ¼ 9; ACP, n ¼ 10)
and postoperatively in 23 neonates (DHCA, n ¼ 11; ACP,
n¼ 12). Results are listed in Table 2. The absolute concentra-
tions of the renal marker GST and intestinal marker I-FABP
were significantly higher postoperatively in the DHCA group
compared with the ACP group (P¼ .03 and P¼ .04, respec-
tively). Regarding the other markers of renal injury (NGAL,
L-FABP, NAG, and KIM-1), the difference of postoperative
values between DHCA and ACP did not reach statistical
significance (P¼ .07, P¼ .61, P¼ .50, and P¼ .14, respec-
tively). When correcting for urine output at the time of
sampling, all markers except NAG and KIM-1 were signifi-
cantly higher postoperatively in the DHCA group than the
ACP group (NGAL, P < .01; GST, P ¼ .02; L-FABP,
P ¼ .03; NAG, P ¼ .11; KIM-1, P ¼ .05; and I-FABP,
P ¼ .01). The median postoperative urine output itself was
1.5 mL $ kg1 $ h1 in the DHCA group vs 3.0 mL $ kg1 $
h1 in the ACP group (P ¼ .10). Stratified by univentricular
and biventricular repair, themedian and ranges for thevarious
biomarkers are listed in Table E1.1326 The Journal of Thoracic and Cardiovascular SurSerum creatinine and blood urea nitrogen levels were
available for a limited number of patients preoperatively
(DHCA, n ¼ 12; ACP, n ¼ 12) and postoperatively
(DHCA, n ¼ 7; ACP, n ¼ 6). For blood urea nitrogen,
a significant difference between postoperative levels was
detected (P ¼ .03) whereas for creatinine this was
P ¼ .05. Results are listed in Table E2.
DISCUSSION
The results of the current study substantiate that in
neonates undergoing complex aortic arch repair, abdominal
organs are better protected by low-flow ACP than by
DHCA. During DHCA, abdominal NIRS values were lower
and lactate concentrations higher than during ACP, likely
resulting in the increased concentrations of renal and
intestinal organ damage markers after surgery.
The current findings confirm earlier suggestions in liter-
ature. Pigula and associates8 were the first to measure evi-
dence of flow in the abdominal aorta during ACP. Since
then, others have assessed abdominal NIRS trends during
ACP and have found that NIRS values rise with increasing
ACP flow rate.5,7,22 Recently, we4 have added to the litera-
ture that DHCA duration during aortic arch reconstruction
is linearly related to the duration of postoperative recovery,
whereas ACP is not. Taken together, these findings strongly
point toward the phenomenon of abdominal perfusion
during ACP.
We intended to assess markers of organ injury as close to
the insult as possible. This explains the choice for thegery c December 2012
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Dbiomarkers used in this study, instead of the more widely
known markers such as creatinine and urea for renal
function. The latter markers are known to measure organ
function and are generally raised 1 to 3 days after surgery,
whereas the current biomarkers in this study are able to de-
tect early organ injury, making factors such as low cardiac
output less likely to obscure results.9 Renal injury was
assessed by 5 different biomarkers. Of these, NGAL has
generally been researched most extensively. Recently, 2
large studies validated the marker in the pediatric cardiac
surgery population and observed that acute kidney injury
could be detected by NGAL as early as 2 hours after surgery
with mean values of 300 to 500 ng/mL.10,11 Krawczeski and
colleagues11 specifically calculated a cutoff point for the
neonatal population at 185 ng/mL. When this is applied to
our cohort, after surgery, 5 of the 12 in the DHCA group
would find themselves above this threshold vs 2 of 13 in
the ACP group. When comparing the concentrations of
the current group of neonates with those reported for all 5
renal biomarkers used in this study, some of the organ injury
markers are already elevated in the patients preoperatively,
likely reflecting the compromised cardiac situation. Postop-
eratively, the values in the DHCA group indicate that
substantial renal injury has occurred, whereas this is much
less the case after ACP.
Previously published articles concerning renal bio-
markers have mostly reported absolute urinary concentra-
tions in their studies.10-17 However, correction to the urine
production at the time of sampling has recently been
stated to be the most reliable way of assessing renal
injury.20 Inasmuch as differences between DHCA and
ACP became especially apparent in the analysis corrected
for urine production, this confirms that DHCA results in
more renal injury than ACP.
Intestinal injury was estimated using I-FABP, which has
been used in both adults and neonates to determine intestinal
ischemia.18,19 Compared with these reports, the preoperative
values are acceptable whereas the postoperative values after
DHCA are among the highest reported, indicating that the
intestinal injury is substantial after DHCA. In contrast, after
ACP, the values seem to be in the normal range.
Abdominal NIRS values during ACP showed a large var-
iation between patients. This is likely due to both a varying
degree of collaterals and a varying duration of ACP. Conse-
quently, this does indicate that abdominal perfusion cannot
be guaranteed in the individual patient during ACP, but at
a group level, ACP does seem to provide protection from
ischemic renal and intestinal injury. The lactate measure-
ments support this notion, inasmuch as these were generally
increased in the DHCA group, whereas they remained
unchanged in the ACP group. Neonates with aortic arch ob-
structions are probably ideal candidates for the advanta-
geous effects of ACP, inasmuch as their anatomy will
have stimulated the growth of collaterals traveling fromThe Journal of Thoracic and Carthe aortic arch and the innominate arteries, via the mam-
mary and epigastric arteries, to the abdominal viscera.23-25
This study has important limitations that deserve consid-
eration. First, apart from NGAL, the various biomarkers
have not been validated in this specific population and the
limited sample size in the current study prevents this. How-
ever, as these markers are known to show early injury,
we chose to primarily assess these instead of the more tra-
ditional markers. These markers are currently as close to
the injury as one can get. Ultimately, histologic assays (in
animal models) can only confirm specific organ injury;
however, a significant limitation to the use of animals is
the different collateralization pattern. The second important
limitation is the small sample size, which will have resulted
in a lower power to detect statistical differences between the
DHCA and ACP groups. Furthermore, despite the random-
ization for DHCA and ACP, the proportion of univentricular
and biventricular patients between the 2 groups is unbal-
anced. To minimize the impact of a low cardiac output state
on biomarker results, we collected urine samples very
shortly after surgery.
In conclusion, the results presented here show that during
neonatal aortic arch reconstruction, ACP provides more ab-
dominal perfusion than does DHCA. As a consequence, this
likely has a protective effect on abdominal organs. The
current results explain findings in previous studies showing
an adverse effect of DHCA, but not ACP, on early postop-
erative recovery.
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TABLE E1. Abdominal biomarkers: Univentricular and biventricular repairs
DHCA ACP
Preoperative
(2V, n ¼ 5; 1V, n ¼ 4)
Postoperative
(2V, n ¼ 7; 1V, n ¼ 4)
Preoperative
(2V, n ¼ 8; 1V, n ¼ 2)
Postoperative
(2V, n ¼ 10; 1V, n ¼ 2)
Absolute urinary concentrations
NGAL
2V 76 (4.0-222) 161 (26-797) 60 (21-168) 79 (27-126)
1V 85 (22-149) 218 (202-235) (8.7-11) (358-560)
GST
2V 4.4 (0.00-5.8) 7.2 (6.4-7.9) 6.1 (4.2-11) 6.1 (1.7-11)
1V 6.5 (5.9-7.0) 7.4 (6.8-8.0) (1.7-3.2) (2.2-2.2)
L-FABP
2V 128 (23-451) 371 (43-615) 236 (13-899) 313 (21-1093)
1V 323 (97-549) 420 (29-811) (79-86) (21-612)
NAG
2V 9.3 (0.10-29) 31 (2.9-119) 13 (0.20-27) 22 (3.3-78)
1V 15 (0.00-31) 42 (13-70) (1.7-5.7) (29-48)
KIM-1
2V 2.0 (0.22-6.5) 4.9 (0.18-13) 1.6 (0.04-8.2) 1.9 (0.02-4.2)
1V 2.5 (1.0-4.0) 9.3 (1.8-17) (0.21-0.71) (0.15-0.35)
I-FABP
2V 40 (6.9-150) 147 (30-205) 19 (0.00-50) 8.9 (0.00-165)
1V 35 (0.00-70) 335 (79-592) (32-36) (6.3-198)
Results corrected for urine output
NGAL
2V 19 (0.61-84) 119 (53-1139) 15 (5.3-42) 27 (4.0-84)
1V 84 (3.2-165) 123 (112-134) (2.0-5.5) (23-373)
GST
2V 1.2 (0.00-4.8) 5.9 (4.8-14) 1.9 (0.67-2.8) 1.6 (0.24-5.8)
1V 3.8 (1.0-6.6) 4.2 (3.8-4.5) (0.74-0.85) (0.14-1.5)
L-FABP
2V 51 (5.3-335) 374 (39-742) 45 (3.2-346) 57 (9.5-336)
1V 312 (14-610) 277 (14-541) (20-41) (14-39)
NAG
2V 3.8 (0.02-7.8) 31 (2.6-88) 3.1 (0.05-6.5) 5.1 (1.2-36)
1V 17 (0.00-34) 21 (8.9-33) (0.40-2.9) (1.9-32)
KIM-1
2V 0.5 (0.03-5.4) 5.8 (0.12-9.8) 0.5 (0.01-2.3) 0.8 (0.00-1.2)
1V 2.3 (0.15-4.4) 4.6 (1.2-8.0) (0.05-0.36) (0.01-0.22)
I-FABP
2V 9.0 (1.0-125) 133 (22-294) 3.9 (0.00-19) 2.8 (0.00-75)
1V 39 (0.00-78) 167 (53-282) (8.8-17) (0.40-132)
Urine output (mL $ kg1 $ h1)
2V 4.8 (1.2-7.0) 1.1 (0.50-8.0) 4.5 (2.6-8.0) 3.0 (1.2-6.8)
1V 2.6 (0.9-6.8) 2.6 (1.5-3.8) (1.75-1.95) (0.25-8.0)
Serum markers (2V, n ¼ 6; 1V, n ¼ 6) (2V, n ¼ 4; 1V, n ¼ 3) (2V, n ¼ 10; 1V, n ¼ 2) (2V, n ¼ 4; 1V, n ¼ 1-2)
Creatinine
2V 50 (36-78) 62 (47-70) 43 (24-59) 52 (41-59)
1V 60 (56-92) 73 (73-75) (43-68) (61-63)
BUN
2V 3.1 (0.50-5.0) 3.1 (1.9-11) 1.8 (0.50-3.2) 2.3 (1.5-6.0)
1V 2.9 (1.6-5.8) 4.1 (2.8-5.5) (3.7-4.0) 4.0
1V, Univentricular; 2V, biventricular; DHCA, deep hypothermic circulatory arrest; ACP, antegrade cerebral perfusion; NGAL, neutrophil gelatinase-associated lipocalin (ng/
mL); GST, gluthatione s-transferase (U/mL); L-FABP, liver fatty acid binding protein (ng/mL); NAG, N-acetyl-b-D-glucosaminidase (mU/mL); KIM-1, kidney injury
molecule-1 (ng/mL); I-FABP, intestinal fatty acid binding protein (ng/mL); BUN, blood urea nitrogen.
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TABLE E2. Serum markers of renal function
DHCA ACP P value
postoperative
(DHCA vs ACP)
Preoperative
(n ¼ 12)
Postoperative
(n ¼ 7)
Preoperative
(n ¼ 12)
Postoperative
(n ¼ 6)
Creatinine 58 (46-69) 70 (54-73) 43 (39-55) 55 (45-60) .05
BUN 2.9 (1.4-4.2) 3.6 (2.9-5.2) 2.0 (1.4-3.1) 2.3 (1.4-3.1) .03
DHCA, Deep hypothermic circulatory arrest; ACP, antegrade cerebral perfusion; BUN, blood urea nitrogen.
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